ロード中...
Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report
Immune checkpoint inhibitors have markedly changed lung cancer treatment and improved overall survival. However, immune checkpoint inhibitors may be associated with various adverse events, including encephalitis, although this complication is rare. We herein describe the clinical characteristics of...
保存先:
| 出版年: | Mol Clin Oncol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327220/ https://ncbi.nlm.nih.gov/pubmed/30680206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1777 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|